Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).

Wainberg Z. A., Enzinger P. C., Kang Y., Yamaguchi K., Qin Shukui Q. S., Lee K., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.3, 2021 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 39 Issue: 3
• Publication Date: 2021
• Doi Number: 10.1200/jco.2021.39.3_suppl.160
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
• Bezmialem Vakıf University Affiliated: Yes